Our investment
In 2016, CDC invested $20 million into EuroMena III, alongside the IFC, the EIB, and other European DFIs, including Germany's DEG and France's Proparco. The fund manager is looking to make between eight to 10 investments of between $10 million to $20 million, and is targeting a total fund size of $150 million. Our investment will support the growth of businesses in the focus regions.
Expected impact
SMEs in the Levant, North Africa and sub-Saharan Africa typically lack access to affordable growth capital, as well as the strategic expertise to enable them to expand their regional footprint.
Our investment will enable the fund manager to provide much-needed capital to fast-growth companies in the FMCG, retail, financial services, education and healthcare sectors to support their expansion. This will support direct and indirect job creation, particularly among women and young people.
The fund manager will also provide managerial, technical and operational expertise to portfolio companies.
The fund has so far made investments in four companies in the FMCG, retail, and banking sectors operating in Nigeria, Tunisia, Morocco, and Algeria and Lebanon.
Environmental and social aspects
We are working closely with the fund manager to improve its existing Environmental and Social Management System, including delivering an action plan.
Key facts
- Status:
- Active
- Region
:
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- Africa
- Sector
:
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people. For funds, the sectors listed here are those the fund has invested in so far.
- Financial services, Manufacturing, Other consumer services
- Website:
- https://protect-eu.mimecast.com/s/TzkWC6RVmSr5Pr3Tp0mZ8N?domain=capitaltrustltd.com
- Investment type
:
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Fund manager:
- EuroMena
- Start date
:
For direct investments, this is the date CDC committed capital to the business or project.
For funds, this is the date that CDC committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- June 2016
- Amount
:
For direct investments, this is the total amount that CDC has committed to the business or project (it may be a combination of equity and debt).
For funds, this is the total amount that CDC has committed to the fund.
- $20m
- Domicile
:
This is the investee company’s place of incorporation; or a fund’s jurisdiction.
- United Kingdom
Investments made by this fund
- Active
- Exited
| Investment name | Country | Region | Sector | Start date | Status |
|---|---|---|---|---|---|
|
Elephant Africa Holding
Elephant Africa Holding is the leading poducer of tissue paper products (including napkins, facial tissues and kitchen towels) in Nigeria. The company controls both Bel Papyrus and Bel Impex. Production is based on paper collected locally and recycled internally and has a large modern distribution network across Nigeria. |
Nigeria | Africa, West Africa | Manufacturing | August 2015 | Active |
|
EuroMena Jasmin
Jasmin is a retail group operating in Tunisia and Morocco. |
Morocco | Africa, North Africa | Other consumer services | November 2015 | Active |
|
Retail Holding
Retail Holding is one of the major retailers in Morocco. Its LabelVie brand is the exclusive franchisee of French giant Carrefour and Retail Holding is also the franchisee for apparel retailer Kiabi, Virgin Megastore and Burger King. It recently started its expansion to Africa, through an investment in CDCI, a supermarket chain in the Ivory Coast. |
Morocco | Africa, North Africa | Other consumer services | May 2017 | Active |
| Carbon Holdings. | January 2018 | Active | |||
|
Novamed
Novamed, Ltd is a leader in the development, manufacturing, and marketing of products used for diagnosing infectious diseases. |
Africa | February 2019 | Active |
